Brazil Threatens To Break Patent On Abbott's Kaletra

Law360, New York (June 26, 2005, 12:00 AM EDT) -- Brazil has vowed to break the patent on U.S. drug maker Abbott Laboratories' HIV drug Kaletra in an effort to cut treatment costs.

Brazilian Health Minister Humberto Costa told local media his government would break the patent as a matter of “public interest.”

He said Abbott would be given 10 days in which to respond and seek a negotiated agreement.

“The Brazilian government will adopt a compulsory licence for the treatment if the manufacturer (Abbott) does not accept the presented terms to guarantee the sustainability of...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.